Our world-renowned experts are transforming the way cancers are prevented, detected, treated and, yes, cured.
Blood diseases are complex, and today, cancer is no longer solely defined by location or even by stage — there is no routine blood cancer or blood disease. Each patient’s disease is different, acting and reacting differently to the bodies they are in and the treatments aimed at stopping them.
Mission
At the OSUCCC – James, the Experimental Hematology team’s mission is to work collaboratively to achieve a singular goal: to create and conduct impactful research that changes the lives of patients with acute myelogenous leukemia (AML), chronic lymphocytic leukemia (CLL), hairy cell leukemia (HCL), mantle cell lymphoma (MCL), sickle cell anemia and auto immune hemolytic anemia (AIHA).
To deliver the most effective cancer prevention, detection, diagnosis and treatment, our world-renowned experts identify and understand blood cancers and blood diseases at the genetic level, unlocking the unique genetic and molecular code of each patient’s disease and pinpointing what makes it grow or cause symptoms — then discovering what stops it. We extend this work to developing therapies focused on impacting patient’s lives to allow either cure or survival living with the disease, absent any symptoms.
Our team comprises talented individuals from a multicultural background who strive to reach the highest accomplishment levels while also maintaining a humble demeanor, respecting each other and sharing knowledge. This enables us to extend in a broad range of directions, without fear of failure, to impact and change patients’ lives. How? As we seamlessly translate our research to the clinic, our highly compassionate care makes every patient feel as if he or she is the most important person here.
Collaboration With Other Ohio State Schools
The Experimental Hematology team actively collaborates with:
The Ohio State University School of Veterinary Medicine, which enables these researchers to analyze treatments used for dogs diagnosed with lymphoma and determine if there is potential promise for helping human patients.
The Ohio State University College of Pharmacy, which enables performance of cellular and plasma pharmacology in interpreting drug effects in animals that have already been diagnosed and are under drug treatment -- and how that might ultimately impact patients.
The Ohio State University College of Engineering, which enables the Experimental Hematology team to apply novel identification and characterization methods to small cell populations as well as deliver targeted therapeutics.